Dergiler / GORM:Gynecology Obstetrics & Reproductive Medicine / 2005 / Cilt: 11 - Sayı: 3

Serum C-reactive protein, uric acid and ferritin levels in gestational diabetes as a screening test

Sayfa
163–166
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CRP alone or combination with GCT was not a powerful screening test for GDM; even CRP reduced unnecessary OGTT when used together with GCT.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To investigate the value of uric acid, ferritin, C-reactive protein (CRP) both alone or in combination as screening tests for gestational diabetes (GDM) confirmed by the gold standard 100-g oral glucose tolerance test (OGTT).
📊
Temel Bulgular & Veri:STUDY DESIGN: A total of 320 pregnant women at 28-31 weeks gestation during the period of study from January-May 2001 were recruited to the study from Social Security Hospital.
💡
Sonuç & Katkı:CRP alone or combination with GCT was not a powerful screening test for GDM; even CRP reduced unnecessary OGTT when used together with GCT.
🔬Tür:Araştırma Makalesi
📍Kapsam:2001 Verileri
⚙️Değişkenler:Diabetes · gestasyonel · C-reaktif protein

Abstract

To investigate the value of uric acid, ferritin, C-reactive protein (CRP) both alone or in combination as screening tests for gestational diabetes (GDM) confirmed by the gold standard 100-g oral glucose tolerance test (OGTT). STUDY DESIGN: A total of 320 pregnant women at 28-31 weeks gestation during the period of study from January-May 2001 were recruited to the study from Social Security Hospital. A total of 91 subjects with a high risk of GDM from 320 subjects who were referred for an OGTT were available for the study. Fasting serum uric acid, ferritin, CRP levels were measured at the time of glucose challenge test (GCT). The area under curve (AUC), the receiver operating characteristic (ROC) curves for uric acid, ferritin, CRP was also calculated. RESULTS: GDM patients had higher CRP levels compared to patients with GCT?140mg/dl and patients with GCT<140 mg/dl, normal OGTT. There was no significantly difference in ferritin and uric acid levels between these groups. Area under curve was 0.827 for CRP in the prediction of the development of GDM. Two cut-off values were used for CRP, the upper to rule in and the lower to rule out GDM. At a cut-off value of ?2 mg/dl to rule out GDM in 91 patients, 38 (42%) would not need OGTT with 33 (87%) being false positives, 16 (17.5%) would need OGTT with 8 (50%) being false positive and 75 (82%) would not need OGTT with 12 (16%) being false negative. At a cut-off value of ?3mg/dl with the maximum specificity to rule in GDM in 91 patients, 16 (17.5%) would need OGTT with 8 (50%) being false positive and 75 (82%) would not need OGTT with 12 (16%) being false negative. When different levels of CRP were added to GCT, at a CRP cut-off of 2.5 mg/dl, 71 would not need an OGTT with only 9 being false negative to rule out GDM in 91 patients CONCLUSIONS: CRP predicted the presence of GDM. CRP alone or combination with GCT was not a powerful screening test for GDM; even CRP reduced unnecessary OGTT when used together with GCT.

🔖

Bu Makaleye Atıf Yap

YILDIRIM, B., AYBEK, H., ROTA, S. S., KAPTANOĞLU, B., KALELİ, B. (2005). Serum C-reactive protein, uric acid and ferritin levels in gestational diabetes as a screening test. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 11 - Sayı: 3, 163–166. https://ajindex.com/articles/227567

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Jimenez-Moleon JJ, Bueno-Cavanillas A, Luna-del- Castillo JD, Lardelli-Claret P, Garcia-Martin M, Galvez- Vargas R. Predictive value of a screen for gestational diabetes mellitus: influence of associated risk factors. Acta Obstet Gynecol Scand 2000; 79:991-8
  2. Coustan DR. Methods of screening for and diagnosing of gestational diabetes. Clin Perinatal 1993; 20:593-602
  3. Hanna FW, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med 2002; 19:351-8
  4. Kyle CV, Cundy TF. Screening for gestational diabetes mellitus: can we be more efficient? Aust N Z J Obstet Gynaecol 2001; 41:285-90
  5. Tarn WH, Rogers MS, Yip SK, Lau TK, Leung TY. Which screening test is the best for gestational impaired glucose tolerance and gestational diabetes mellitus? Diabetes Care 2000; 23:1432
  6. Hadden D. Evidence-based screening for gestational diabetes? Diabet Med 2000; 17:402-4
  7. Agarwal MM, Hughes PF, Punnose J, Ezimokhai M. Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population. Diabet Med 2000; 17:720-6
  8. Bonomo M, Gandini ML, Mastropasqua A, et al. Which cutoff level should be used in screening for glucose intolerance in pregnancy? Definition of Screening Methods for Gestational Diabetes Study Group of the Lombardy Section of the Italian Society of Diabetology. Am J Obstet Gynecol 1998; 179:179-85
  9. Metzger B, Coustan D. Summary And Recommendations Of The Fourth International Workshop-Conference On Gestational Diabetes Mellitus. Diabetes Care 1998; 21:161-7
  10. Freeman DJ, Norrie J, Caslake MJ, et al. West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51:1596-600
  11. Han T, Satar N, Williams K, Gonzalez- villalpando C, Lean M, Haffner S. Prospective study to the developmentof diabetes and metabolic syndrome in the mexico city study diabetes study. Diabetes Care 2002; 25:2016-21
  12. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002; 2:126-30
  13. Costa A, Iguala I, Bedini J, Quinto L, Conget I. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism 2002; 51:372-5
  14. Eshed I, Elis A, Lishner M. Plasma ferritin and type 2 diabetes mellitus: a critical review. Endocr Res 2001; 27:91-7
  15. Ford ES, Cogswell ME. Diabetes and serum fe